Literature DB >> 10069453

Defining the substrate specificity of cdk4 kinase-cyclin D1 complex.

R H Grafstrom1, W Pan, R H Hoess.   

Abstract

cdk4 kinase-cyclin D1 complex (cdk4/D1) does not phosphorylate all of the sites within retinoblastoma protein (Rb) equally. Comparison of five phosphorylation sites within the 15 kDa C domain of Rb indicates that Ser795 is the preferred site of phosphorylation by cdk4/D1. A series of experiments has been performed to determine the properties of this site that direct preferential phosphorylation. For cdk4/D1, the preferred amino acid at the third position C-terminal to the phosphorylated serine/threonine is arginine. Substitution of other amino acids, including a conservative change to lysine, has dramatic effects on the rates of phosphorylation. This information has been used to mutate less favorable sites in Rb, converting them to sites that are now preferentially phosphorylated by cdk4/D1. A conserved site at Ser842 in the related pocket protein p107 is also preferentially phosphorylated by cdk4/D1. Although Rb and p107 differ significantly in sequence, the Rb Ser795 site can replace the p107 Ser842 site without affecting the rate of phosphorylation. These results suggest that although a determinant of specificity resides in the sequences surrounding the phosphorylated site, the structural context of the site is also a critical parameter of specificity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069453     DOI: 10.1093/carcin/20.2.193

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

1.  The midblastula transition in Xenopus embryos activates multiple pathways to prevent apoptosis in response to DNA damage.

Authors:  C V Finkielstein; A L Lewellyn; J L Maller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Crystal structure of human CDK4 in complex with a D-type cyclin.

Authors:  Philip J Day; Anne Cleasby; Ian J Tickle; Marc O'Reilly; Joe E Coyle; Finn P Holding; Rachel L McMenamin; Jeff Yon; Rajiv Chopra; Christoph Lengauer; Harren Jhoti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

3.  Covalent Modification of CDK2 by 4-Hydroxynonenal as a Mechanism of Inhibition of Cell Cycle Progression.

Authors:  Jeannie M Camarillo; Kristie L Rose; James J Galligan; Shu Xu; Lawrence J Marnett
Journal:  Chem Res Toxicol       Date:  2016-03-11       Impact factor: 3.739

4.  CDK4 Amplification Reduces Sensitivity to CDK4/6 Inhibition in Fusion-Positive Rhabdomyosarcoma.

Authors:  Mary E Olanich; Wenyue Sun; Stephen M Hewitt; Zied Abdullaev; Svetlana D Pack; Frederic G Barr
Journal:  Clin Cancer Res       Date:  2015-03-25       Impact factor: 12.531

5.  Insulin/IGF-I regulation of necdin and brown adipocyte differentiation via CREB- and FoxO1-associated pathways.

Authors:  Aaron M Cypess; Hongbin Zhang; Tim J Schulz; Tian Lian Huang; Daniel O Espinoza; Karsten Kristiansen; Terry G Unterman; Yu-Hua Tseng
Journal:  Endocrinology       Date:  2011-08-23       Impact factor: 4.736

6.  Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix.

Authors:  Benjamin R Topacio; Evgeny Zatulovskiy; Sandra Cristea; Shicong Xie; Carrie S Tambo; Seth M Rubin; Julien Sage; Mardo Kõivomägi; Jan M Skotheim
Journal:  Mol Cell       Date:  2019-04-11       Impact factor: 17.970

7.  The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1.

Authors:  Jennifer L McCann; Madeline M Klein; Evelyn M Leland; Emily K Law; William L Brown; Daniel J Salamango; Reuben S Harris
Journal:  J Biol Chem       Date:  2019-06-19       Impact factor: 5.157

8.  Multiple mechanisms for E2F binding inhibition by phosphorylation of the retinoblastoma protein C-terminal domain.

Authors:  Jason R Burke; Tyler J Liban; Tamara Restrepo; Hsiau-Wei Lee; Seth M Rubin
Journal:  J Mol Biol       Date:  2013-10-05       Impact factor: 5.469

9.  CDK4: A Key Player in the Cell Cycle, Development, and Cancer.

Authors:  Stacey J Baker; E Premkumar Reddy
Journal:  Genes Cancer       Date:  2012-11

10.  Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4.

Authors:  Maura Wallace; Kathryn L Ball
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.